Metropolis Healthcare Limited (NSE:METROPOLIS)

Market Cap	84.72B
Revenue (ttm)	13.17B
Net Income (ttm)	1.52B
Shares Out	51.27M
EPS (ttm)	29.57
PE Ratio	55.88
Forward PE	41.74
Dividend	4.00 (0.24%)
Ex-Dividend Date	n/a

Volume	167,007
Average Volume	236,756
Open	1,683.40
Previous Close	1,678.10
Day's Range	1,629.10 - 1,686.10
52-Week Range	1,551.05 - 2,318.30
Beta	0.37
RSI	32.43
Earnings Date	Feb 7, 2025

About Metropolis Healthcare

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laborat...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1981
• Employees: 4,313
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: METROPOLIS

Financial Performance

In 2023, Metropolis Healthcare's revenue was 12.08 billion, an increase of 5.18% compared to the previous year's 11.48 billion. Earnings were 1.28 billion, a decrease of -10.54%.